BioPharmSignal logoBioPharmSignal

Biotech News

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Neuronetics (STIM)NeuroneticsCompany update

Nir Naor appointed Chief Financial Officer effective July 23, 2026, bringing more than 20 years of finance and life sciences experience Cory Anderson promoted to Executive Vice President and General Manager, Greenbrook effective July 1, 2026 Andrew Macan to step down as Executive Vice President,

Related news

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

STIMNeuronetics2026-06-02 20:30 EST

Neuronetics Appoints Robert Greene as Senior Vice President Sales

SSKNStrata Skin Sciences2026-07-28 13:15 EST

STRATA Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan as Chief Executive Officer

IARTIntegra LifeSciences2026-07-02 12:30 EST

Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer

CVRXCVRx2026-06-09 11:30 EST

CVRx Announces Chief Financial Officer Transition

RXSTRxSight2026-07-15 20:15 EST

RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer

SGHTSight Sciences2026-07-22 20:05 EST

Sight Sciences to Report Second Quarter 2026 Financial Results on August 5, 2026

ATRCAtriCure2026-07-02 12:00 EST

AtriCure to Announce Second Quarter 2026 Financial Results

View all latest news

Neuronetics

Neurohealth Technology and Care Delivery Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy. NeuroStar Advanced Therapy NeuroStar uses...

Recent company news

STIMNeuronetics2026-08-03 12:00 EST

Neuronetics and Jorey Chernett Announce Shared Vision

STIMNeuronetics2026-07-31 21:00 EST

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

STIMNeuronetics2026-07-28 12:32 EST

Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland

STIMNeuronetics2026-07-28 12:30 EST

Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call

STIMNeuronetics2026-07-20 20:05 EST

Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes

Stock data

Close
2.25 USD
Market cap
108.56M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States